Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a single-center experience with 63 patients.

CONCLUSIONS: IVIG showed adequate tolerance and effectiveness in selected severe SLE manifestations, mainly hematological involvement. It was useful for concomitant infection.
PMID: 31653191 [PubMed - as supplied by publisher]

Source: Lupus - October 24, 2019 Category: Rheumatology Authors: Nieto-Aristizábal I, Martínez T, Urbano MA, Posso-Osorio I, Plata IF, Garcia-Robledo JE, Aragón CC, Santos VA, Tobón GJ Tags: Lupus Source Type: research